Mesothelioma cancer
Peritoneal Mesothelioma Patients May Find Relief With New Treatment
By Adminby Peter Kent
Researchers recently published the results of a study in the Journal of Clinical Oncology detailing a potentially new treatment for patients of abdominal mesothelioma that will likely improve the condition for patients. The study found that when patients suffering from abdominal mesothelioma were given a combination of two drugs, Alimta (pemetrexed) and Gemzar (gemcitabine), their condition improved. The following are the results of the study:
* Response rate among patients was 15 percent.
* The control rate of the disease for patients while on the medication was 50 percent.
* The median time to disease progression was 10.4 months.
* The median survival time was 26.8 months.....more
(0) Reader Feedback |
Email Article | 
Email Us | 
Print friendly
| Admin Most recent columns |
